GSK PLC Adrhedged (GSKH) closed at $72.30 on November 10, 2026, up 0.4% from the previous close, on volume of 1,509 shares (30-day average 316).
Data as of November 10, 2026.
10-Nov-2026
No press releases found.
A 17-Month High in the Dollar, and the Ten ADRhedged™ ETFs That Held Their Ground Against It
TipRanks (Mon, 9-Nov 7:00 AM ET)
GSK plc ADRhedged seeks to provide investment results that correspond generally, before fees and expenses, to the total return of the ordinary shares of GSK plc in its local market. GSK Plc is a UK-listed multinational pharmaceutical company based around two divisions: Prescription medicines (Includes ViiV HIV joint venture with Pfizer and Shionogi) and Vaccines. In prescription drugs and Vaccines its key franchises include HIV & Shingrix (shingles vaccine). Under normal circumstances, fund invests at least 95% of its net assets in American Depositary Receipts ("ADRs") of GSK plc . The Series will not invest directly in the Company. The Series invests in the ADRs of the Company (the "Portfolio Securities") and a currency swap (the "Currency Hedge Contract") designed to hedge against fluctuations in the exchange rate between the U.S. dollar and the British pound ("Local Currency"). The Currency Hedge Contract is with a counterparty acting as principal. The notional value of the Currency Hedge Contract is adjusted daily based on the current value of the Portfolio Securities.
GSK PLC Adrhedged trades on the BATS stock market under the symbol GSKH.
As of November 10, 2026, GSKH stock price climbed to $72.30 with 1,509 million shares trading.
GSKH has a market cap of $722,984.00. This is considered a Sub-Micro Cap stock.
GSKH has underperformed the market in the last year with a return of +11.3%, while SPY returned +12.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in GSKH shares. However, GSKH has outperformed the market in the last 3 month and 2 week periods, returning -1.4% and +0.5%, while SPY returned -2.8% and -2.0%, respectively. This indicates GSKH has been having a stronger performance recently.
GSKH support price is $69.15 and resistance is $74.82 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that GSKH shares will trade within this expected range on the day.
